Ultrasound-guided percutaneous thoracoabdominal biopsy. Efficacy, cost-effectiveness and safety

M, Ojalehto; Tikkakoski, Tapani; Rissanen, Tiina H.; Apaja‐Sarkkinen, M.

doi:10.1034/j.1600-0455.2002.430210.x

Cited by 6 publications

(4 citation statements)

References 67 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The absence of metastases in puncture channels in our study, however, does not completely rule them out, because follow-up beyond the necessary period of 3 weeks to 48 months was not performed [29]. However, such metastases do occur more commonly after puncture of pancreatic and renal tumors [2,30]. Patient survival is, however, not limited if resectable or ablative treatment follows [31,32].…”

Section: Discussioncontrasting

confidence: 50%

“…They are performed only for patients with suspicion of non-resectable adenocarcinoma in palliative situations [1]. For these patients, pancreatic biopsy does not negatively affect overall survival, and data obtained by use of this method are highly relevant in determining appropriate chemotherapy [2]. In a potentially curative situation, on the other hand, the carcinoma should be surgically removed as quickly as possible.…”

Section: Introductionmentioning

confidence: 98%

See 1 more Smart Citation

Sonographically guided puncture of the pancreas: incidence of complications, and risk factors

et al. 2012

View full text Add to dashboard Cite

show abstract

Section: Discussioncontrasting

confidence: 50%

Section: Introductionmentioning

confidence: 98%

Sonographically guided puncture of the pancreas: incidence of complications, and risk factors

et al. 2012

View full text Add to dashboard Cite

show abstract

“…In most of the cases, it did not change treatment choice but increased clinicians confidence in the choice, since it established the probable line of treatment as final line of treatment. We can avoid number of investigations especially invasive ones, it helps in decreasing morbidity and mortality, shortening hospitalization and hence is costeffective [4][5][6]12,16,17,19] So, overall the procedure US- …”

Section: Discussionmentioning

confidence: 99%

Ultrasound guided percutaneous fine needle aspiration biopsy / automated needle core biopsy of abdominal lesions: Effect on management and cost effectiveness

Gani¹,

Shafee²,

Soliman³

2011

Ann Afr Med

View full text Add to dashboard Cite

Aims: This prospective study was designed to determine whether ultrasound (US)-guided percutaneous fi ne needle aspiration biopsy (PFNAB)/US-guided percutaneous needle core biopsy (PNCB) of abdominal lesions is effi cacious in diagnosis, is helpful in treatment choice, to evaluate whether various other investigations can be avoided, especially invasive ones, its time (shortening hospitalization) and cost-effectiveness. Materials and Methods: A total 159 US-guided PFNAB (67) and US-guided automated PNCB (92) of abdominal lesions were performed percutaneously in 150 patients; the youngest patient was a 3-month-old female and eldest was a 75-year-old female. The patient selection was irrespective of age, sex, or location of the abdominal lesion. These patients presented with abdominal mass/lesions, suspected malignancy, jaundice, and in some cases, however, biopsy was performed to determine the nature of indeterminate lesion (malignant / benign versus abscesses). They were 47 hepatobiliary, 6 pancreas, 24 gastrointestinal tract (GIT), 20 kidneys and urinary bladder, 20 prostate, 3 lymph nodes, 4 adrenals, 8 retroperitoneal, 13 ovaries, and 9 other types of lesions. We used free-hand technique (without biopsy attachment) in 129 cases, and transrectal and transvaginal with biopsy attachment was used in 30 cases. Results: In 91.99% of cases, US-guided PFNAB/US-guided PNCB contributed signifi cantly to diagnosis in which USguided PFNAB/US-guided PNCB was the diagnostic test in 23.33% cases. It confi rmed a highly suspected diagnosis in 64% patients, and indicated a specifi c diagnosis that was not suspected in the remaining 36%. In 57.33% cases, the results of US-guided PFNAB/US-guided PNCB, did not alter treatment choice but increased physician confi dence in the choice. US-guided PFNAB/US-guided PNCB was responsible in avoiding 107 planned investigations, including 8 laparotomies, with no signifi cant complications and decreasing length of stay and resulting in 20% cost savings. Conclusions: Thus, the US-guided PFNAB/US-guided PNCB contributed signifi cantly in diagnosis, and in most of the cases it did not change treatment choice but increased clinicians confi dence in the choice. We can avoid the number of investigations, decrease morbidity and mortality, shorten hospitalization and cost by using these methods.Key-words: Biopsy, cost-effectiveness, effect on diagnosis, effect on treatment, percutaneous fi ne needle aspiration biopsy, percutaneous needle core biopsy, ultrasound RésuméObjectifs: Cette étude prospective a été conçue afi n de déterminer si l'échographie (US)-guidé percutanée fi ne aiguille biopsie d'aspiration (PFNAB) / biopsie guidée par U.S. percutanée aiguille (PNCB) des lésions abdominales est effi cacious en diagnostic, est utile dans le choix de traitement, d'évaluer si les divers autres enquêtes peuvent être évités, surtout envahissantes, son temps (raccourcissement hospitalisation) et la rentabilité.

show abstract

“…As technology has improved, CT/ultrasound-guided fine-needle aspiration (FNA) or core biopsy have developed into dependable and minimally invasive alternatives for acquiring tissue. Oftentimes, however, the tissue obtained is not sufficient for histologic evaluation or the location of the adenopathy is not amenable to a CT/ultrasound (US)-guided biopsy [2][3][4][5]. While laparotomy remains the gold standard for retroperitoneal lymph node biopsy, it is an invasive procedure associated with prolonged hospital stay and subsequent recovery time.…”

mentioning

confidence: 99%

Efficacy of laparoscopic mesenteric/retroperitoneal lymph node biopsy

et al. 2008

View full text Add to dashboard Cite

show abstract

Ultrasound-guided percutaneous thoracoabdominal biopsy. Efficacy, cost-effectiveness and safety

Abstract: This review will discuss the benefits and disadvantages of ultrasound-guided percutaneous fine-needle aspiration and cutting needle biopsies. Clinical efficacy, cost-effectiveness, some controversies and safety will be reviewed.

Cited by 6 publications

References 67 publications

Sonographically guided puncture of the pancreas: incidence of complications, and risk factors

Sonographically guided puncture of the pancreas: incidence of complications, and risk factors

Ultrasound guided percutaneous fine needle aspiration biopsy / automated needle core biopsy of abdominal lesions: Effect on management and cost effectiveness

Efficacy of laparoscopic mesenteric/retroperitoneal lymph node biopsy

Contact Info

Product

Resources

About